VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 79 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $169,958 | -22.9% | 21,930 | +14.0% | 0.00% | – |
Q2 2023 | $220,298 | +45.9% | 19,240 | -39.9% | 0.00% | – |
Q1 2021 | $151,000 | -43.0% | 32,000 | -13.5% | 0.00% | – |
Q4 2020 | $265,000 | -32.9% | 37,000 | 0.0% | 0.00% | – |
Q3 2020 | $395,000 | -18.6% | 37,000 | -3.6% | 0.00% | – |
Q2 2020 | $485,000 | +51.6% | 38,400 | +9.7% | 0.00% | – |
Q1 2020 | $320,000 | -23.3% | 35,000 | +17.1% | 0.00% | – |
Q4 2019 | $417,000 | -19.0% | 29,900 | 0.0% | 0.00% | – |
Q3 2019 | $515,000 | -45.5% | 29,900 | -13.8% | 0.00% | -100.0% |
Q2 2019 | $945,000 | +48.4% | 34,700 | +4.2% | 0.00% | – |
Q1 2019 | $637,000 | +130.8% | 33,300 | +13.3% | 0.00% | – |
Q4 2018 | $276,000 | -44.6% | 29,400 | +11.8% | 0.00% | – |
Q3 2018 | $498,000 | +7.1% | 26,300 | +10.5% | 0.00% | – |
Q2 2018 | $465,000 | +56.6% | 23,800 | +50.6% | 0.00% | – |
Q1 2018 | $297,000 | +40.8% | 15,800 | +24.4% | 0.00% | – |
Q4 2017 | $211,000 | -2.3% | 12,700 | +21.0% | 0.00% | – |
Q3 2017 | $216,000 | +129.8% | 10,500 | 0.0% | 0.00% | – |
Q2 2017 | $94,000 | – | 10,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 6,391,176 | $109,992,000 | 62.32% |
Foresite Capital Management IV, LLC | 830,565 | $14,294,000 | 4.62% |
Casdin Capital, LLC | 1,128,075 | $19,414,171,000 | 2.01% |
ARMISTICE CAPITAL, LLC | 1,096,000 | $18,862,000 | 1.25% |
Bellevue Group AG | 2,704,683 | $46,548,000 | 0.87% |
PFM Health Sciences, LP | 1,231,954 | $21,202,000 | 0.63% |
Boxer Capital, LLC | 500,000 | $8,605,000 | 0.62% |
Aevitas Wealth Management, Inc. | 23,150 | $398,000 | 0.40% |
361 CAPITAL LLC | 120,143 | $2,068,000 | 0.38% |
Birchview Capital, LP | 30,000 | $516,000 | 0.34% |